According to the Globe, the volunteer who died was a 28-year-old male doctor. Since March this year, he has been working in a hospital in Rio and has been fighting the epidemic. It is reported that the volunteer was in good health before. In late July, he was vaccinated with a vaccine jointly developed by Oxford University and AstraZeneca, and a Brazilian volunteer who participated in the COVID-19 vaccine trial at Oxford University died. The Brazilian National Health Supervision Bureau (Anvisa) said that it was officially informed of this information, and the authenticity of this information has been confirmed. But in September this year, he died of COVID-19 infection, COVID-19 and complications. The specific cause of death is still under investigation, and it is not certain whether it was caused by vaccination.
It is understood that the vaccine jointly developed by Oxford University and AstraZeneca has started phase III clinical trials in Brazil. Up to now, 8000 volunteers in Brazil have participated in this research. Earlier, Brazilian President Bossonaro signed a temporary measure to allow the federal government to allocate 654.38+09 billion reais (about 2.2 billion yuan) to purchase 654.38+00 billion doses of Oxford vaccine.
According to the Brazilian news website? G 1？ It said that Anvisa did not disclose whether the volunteers were vaccinated or placebo. The agency said that according to the ethical confidentiality commitment, relevant data will not be disclosed. Anvisa said that the agency will stick to its mission of protecting the health of Brazilians, and suggested continuing to study the Oxford vaccine. The research and development of vaccines did not stop because of the death of volunteers. On the contrary, large-scale clinical trials continued.
A public health expert told reporters? Considering the surge of confirmed cases in COVID-19, Brazil, the demand for vaccines is very urgent. If clinical trials are stopped now, it may not be in line with public opinion. ?
At present, Brazil has the second largest number of confirmed cases of COVID-19 infection in the world, second only to the United States.
Many foreign people say that they want to be vaccinated with the vaccine developed in China, and we also hope that foreign countries can develop it successfully as soon as possible! After all, life safety is above everything else.